Anticoagulation in COVID-19: It Is Time for High-Quality Evidence
- PMID: 33059827
- PMCID: PMC7550042
- DOI: 10.1016/j.jacc.2020.09.008
Anticoagulation in COVID-19: It Is Time for High-Quality Evidence
Keywords: COVID-19; anticoagulants; randomized controlled trials.
Comment on
-
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.J Am Coll Cardiol. 2020 Oct 20;76(16):1815-1826. doi: 10.1016/j.jacc.2020.08.041. Epub 2020 Aug 26. J Am Coll Cardiol. 2020. PMID: 32860872 Free PMC article.
References
-
- Poissy J., Goutay J., Caplan M. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142:184–186. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical